Brevan Howard Capital Management’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$716K	Buy	+62,871	New	+$716K	﹤0.01%	1128
2025 Q1	–	Sell	-21,495	Closed	-$405K	–	1315
2024 Q4	$405K	Buy	+21,495	New	+$405K	﹤0.01%	653
2024 Q1	–	Sell	-11,068	Closed	-$114K	–	1192
2023 Q4	$114K	Buy	+11,068	New	+$114K	﹤0.01%	895